Experiences Using a Multidisciplinary Model for Treating Injection Drug Use Associated Infections: A Qualitative Study

Experiences Using a Multidisciplinary Model for Treating Injection Drug Use Associated Infections: A Qualitative Study

BackgroundOver the past two decades, the United States has experienced a dramatic increase in the rate of injection drug use, injection associated infections, and overdose mortality. A hospital-based program for treating opioid use disorder in people who inject drugs presenting with invasive infecti...

Full description

Bibliographic Details
Main Authors:	Nathanial S. Nolan, Emily Gleason, Laura R. Marks, Tracey Habrock-Bach, Stephen Y. Liang, Michael J. Durkin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Psychiatry
Subjects:	persons who inject drugs opioid use disorder substance use disorder AMA discharge medications for opioid use disorder
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2022.924672/full

Similar Items

Patient evaluation of a smartphone application for telehealth care of opioid use disorder
by: Jordon D. Bosse, et al.
Published: (2022-09-01)

Care cascade for patients with opioid use disorder and serious injection related infections
by: Anand Upadhyaya, et al.
Published: (2021-11-01)

Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA)
by: Sean T. Allen, et al.
Published: (2023-12-01)

Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy
by: Scott John, et al.
Published: (2023-07-01)

Effect of police action on low-barrier substance use disorder service utilization
by: Karrin Weisenthal, et al.
Published: (2022-07-01)

Attending a Biopsychosocially Focused Buprenorphine Training Improves Clinician Attitudes
by: Holly Ann Russell, et al.
Published: (2021-08-01)

A conceptual framework for how structural changes in emerging acute substance use service models can reduce stigma of medications for opioid use disorder
by: Timothy D. Becker, et al.
Published: (2023-09-01)

Naltrexone Implant for Opioid Use Disorder
by: Amber N. Edinoff, et al.
Published: (2021-12-01)

Health care workers’ perspectives on care for patients with injection drug use associated infective endocarditis (IDU-IE)
by: Saira Butt, et al.
Published: (2022-05-01)

Editorial: Broadening the scope of addiction medicine: Integrating co-morbid conditions, polysubstance use, and patient experiences into substance use treatment
by: Matthew S. Ellis, et al.
Published: (2022-11-01)

Attitudes and training related to substance use in pediatric emergency departments
by: Ariel M. Hoch, et al.
Published: (2022-10-01)

Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study
by: Megan E. Gray, et al.
Published: (2018-10-01)

Shifting Pathways of Stimulant Use Among Individuals With Opioid Use Disorder: A Retrospective Analysis of the Last Thirty Years
by: Matthew S. Ellis, et al.
Published: (2021-12-01)

Sex Specific Sleep Parameters Among People With Substance Use Disorder
by: Caitlin E. Martin, et al.
Published: (2022-05-01)

Sex-related differences in the prevalence of substance use disorders, treatment, and overdose among parents with young children
by: Yitong (Alice) Gao, et al.
Published: (2023-06-01)

Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder
by: Laura R. Marks, et al.
Published: (2024-01-01)

Patient reported preferences for sleep interventions among women receiving buprenorphine for opioid use disorder
by: Michelle Eglovitch, et al.
Published: (2023-09-01)

Acute pain and self-directed discharge among hospitalized patients with opioid-related diagnoses: a cohort study
by: Peggy Compton, et al.
Published: (2021-12-01)

Comorbid Opioid Use Disorder in Body Dysmorphic Disorder
by: J. Kim, et al.
Published: (2022-06-01)

Utilization of addiction treatment among U.S. adults with history of incarceration and substance use disorders
by: Jack Tsai, et al.
Published: (2019-03-01)

Treating opioid use disorders in the criminal justice system with pharmacotherapy
by: Susan Schenk, et al.
Published: (2020-11-01)

A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States
by: John J. Chiosi, et al.
Published: (2023-07-01)

Opioid treatment program safety measures during the COVID-19 pandemic: a statewide survey
by: Sachini Bandara, et al.
Published: (2022-03-01)

Randomized Controlled Trial of Electronic Care Plan Alerts and Resource Utilization by High Frequency Emergency Department Users with Opioid Use Disorder
by: Niels Rathlev, MD, et al.
Published: (2016-01-01)

The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review
by: Alison Adams, et al.
Published: (2023-09-01)

“My Addiction Doesn’t Define Me”—Experiences of Stigma among Mothers with Opioid Use Disorder
by: Christine Bakos-Block, et al.
Published: (2024-01-01)

Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team
by: David P. Serota, et al.
Published: (2021-01-01)

The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy
by: Leen Naji, et al.
Published: (2017-03-01)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
by: Megan K Reed, et al.
Published: (2022-12-01)

Polysubstance use and post-discharge mortality risk among hospitalized patients with opioid use disorder
by: Karli R. Hochstatter, et al.
Published: (2023-12-01)

The motives and methods of methamphetamine and ‘heroin’ co-use in West Virginia
by: Jeff Ondocsin, et al.
Published: (2023-07-01)

Overlapping mechanisms of stress-induced relapse to opioid use disorder and chronic pain: Clinical implications
by: Udi E Ghitza
Published: (2016-05-01)

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
by: Kaley Parchinski, et al.
Published: (2023-06-01)

Medicaid expansion in Oregon and postpartum healthcare among people with and without prenatal substance use disorder
by: Sarah C. Haight, et al.
Published: (2022-12-01)

Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study
by: Jamie Carter, et al.
Published: (2022-11-01)

Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study
by: Daniel M. Hartung, et al.
Published: (2022-08-01)

Intravenous misuse of slow-release oral morphine capsules: how much morphine is injected?
by: Célian Bertin, et al.
Published: (2023-04-01)

Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients
by: Jennifer McNeely, et al.
Published: (2023-09-01)

«One prick and then it´s done»: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment
by: Maximilian Meyer, et al.
Published: (2021-12-01)

Nalmefene Hydrochloride: Potential Implications for Treating Alcohol and Opioid Use Disorder
by: Green M, et al.
Published: (2024-04-01)